Balt published research on the evolution of musculoskeletal embolization, highlighting GAE, transferable embolization, and underlying concepts.
Published
Signal category
Research & Knowledge
Quote
โA very stimulating session in Copenhagen with ๐ ๐ฅ๐จ๐ซ๐ข๐๐ง ๐ ๐ฅ๐๐๐ค๐๐ง๐ฌ๐ญ๐๐ข๐ง & ๐๐ฅ๐๐ฏ๐ข๐๐ ๐๐จ๐ฏ๐๐๐ข๐, highlighting how rapidly the field of ๐ฆ๐ฎ๐ฌ๐๐ฎ๐ฅ๐จ๐ฌ๐ค๐๐ฅ๐๐ญ๐๐ฅ ๐๐ฆ๐๐จ๐ฅ๐ข๐ฌ๐๐ญ๐ข๐จ๐ง is evolving.โ
โ Balt team
Company
- Industry
- Medical Equipment Manufacturing
- Location
- Montmorency, FR
- Company size
- 619 employees
We are Balt. Physician-inspired innovations. Patient-focused solutions. For more than 45 years, Balt has been leading the way โ collaborating with physicians and institutions to develop elegant neurovascular solutions. As the premier global neurovascular platform, always seeking to expand beyond boundaries, we are now bringing our innovation to the peripheral vascular space. We introduced the first neurovascular intervention device in 1977. Now, we offer the worldโs broadest portfolio of medical devices for ischemic and hemorrhagic stroke, as well as devices for peripheral embolization. In 2015, we embarked on an ambitious journey and more than quintupled our revenue and workforce, and that was only the beginning. Now, Balt includes more than 950 talented team members at 16 sites/offices around the world. Be a part of our future: www.baltgroup.com
Founded 1977